In agreement with this notion, the previous study has reported that inhibition of the PD-1/PD-L1 axis increases CD8(+) CTLs and inhibits rhabdomyosarcoma in CXCR2-deficient mice 79. The gene discussed is CD8A; the disease is rhabdomyosarcoma.